Form 8-K - Current report:
SEC Accession No. 0001023024-25-000099
Filing Date
2025-09-26
Accepted
2025-09-26 17:03:10
Documents
12
Period of Report
2025-09-26
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ani-20250926.htm   iXBRL 8-K 28895
  Complete submission text file 0001023024-25-000099.txt   143813

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ani-20250926.xsd EX-101.SCH 1755
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ani-20250926_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ani-20250926_pre.xml EX-101.PRE 12491
14 EXTRACTED XBRL INSTANCE DOCUMENT ani-20250926_htm.xml XML 2690
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 251351300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)